OpiophobiaNCT06536283
Opiophobia in Postsurgical Adults With Cancer
An observational study of Opiophobia, run by M.D. Anderson Cancer Center at 1 site in United States.
Trial summary
To learn how people who underwent surgery feel about their prescribed opioid medication after they leave the hospital. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Opiophobia
- What is being tested?
- 13-item Barriers Questionnaire (BQ-13), Four-item Medication Adherence Questionnaire and 14-item Hospital Anxiety and Depression Scale (HADS)
- How many people
- 50 participants
- Where
- 1 siteUnited States
- Study dates
- 16 Sep 2024to 31 Dec 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: MD Anderson Cancer Center
Who may be able to join
- Adult patient with cancer admitted for cancer-related surgery
- inpatient surgical hospital stay lasting at least 23 hours
- discharged home with a prescription for opioid analgesics
- able to read, speak, and consent in English.
Who cannot join
- Age less than 18 years
- not discharged with a prescription for opioid analgesia to manage pain
- individuals for whom there is documentation of inability to provide consent in the medical record.
Trial locations and contacts
1 site in 1 country.
United States1 site
The Univerisity of Texas M. D. Anderson Cancer Center
Houston, Texas, 77030
About this study
To learn how people who underwent surgery feel about their prescribed opioid medication after they leave the hospital.
Read the detailed description
To explore the barriers and fears related to use of opioids among a population of adults who underwent surgery for cancer who were prescribed opioids for home use during the first week following hospital discharge for a surgical treatment of a malignancy.
- Conditions
- Opiophobia
- Being tested
- 13-item Barriers Questionnaire (BQ-13), Four-item Medication Adherence Questionnaire, 14-item Hospital Anxiety and Depression Scale (HADS)
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
13-item Barriers Questionnaire (BQ-13)Other
Given by questionnaire
Four-item Medication Adherence QuestionnaireOther
Given by questionnaire
14-item Hospital Anxiety and Depression Scale (HADS)Other
Given by questionnaire
| Study group | Role | What they receive |
|---|---|---|
| Opiophobia in Postsurgical Adults | Participants that agree to take part in this study, partiicpants will have a virtual visit, via Zoom, about 7 days after you are discharged from the hospital. The visit will take about 20 minutes, and you will meet with a member of the research team to complete several questionnaires. Receives: Other: 13-item Barriers Questionnaire (BQ-13); Other: Four-item Medication Adherence Questionnaire; Other: 14-item Hospital Anxiety and Depression Scale (HADS) |
What is being measured
The primary outcome is the main question the study is designed to answer.
To explore the barriers and fears related to use of opioids among a population of adults who underwent surgery for cancer.
Use of opioids among a population of adults who underwent surgery for cancer.
Measured: Through study completion, an average of 1 year.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Aug 2024
- Study start16 Sep 2024
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for OpiophobiaStudies of the same condition, open and under way.
- More trials run by M.D. Anderson Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- M.D. Anderson Cancer Center
- Sponsor type
- University, hospital or other
- Collaborators
- Sigma Theta Tau International
- Responsible party
- Sponsor
- Investigators
- Eileen Hacker, PHD,RN, Principal investigator, M.D. Anderson Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06536283
- Sponsor's protocol ID
- 2024-0315
- Other IDs
- NCI-2024-06535
- Status last verified
- Oct 2026
- First submitted
- 31 Jul 2024
- Last updated
- 7 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 7 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Opiophobia in Postsurgical Adults With Cancer
- ClinicalTrials.gov ID
- NCT06536283
- Acronym / sponsor ID
- 2024-0315
- Conditions
- Opiophobia
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- M.D. Anderson Cancer CenterUniversity, hospital or other
- Collaborators
- Sigma Theta Tau International
- Study start
- 16 Sep 2024 (actual)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 2 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To learn how people who underwent surgery feel about their prescribed opioid medication after they leave the hospital.
Detailed description
To explore the barriers and fears related to use of opioids among a population of adults who underwent surgery for cancer who were prescribed opioids for home use during the first week following hospital discharge for a surgical treatment of a malignancy.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Opiophobia in Postsurgical Adults | – | Other: 13-item Barriers Questionnaire (BQ-13), Other: Four-item Medication Adherence Questionnaire, Other: 14-item Hospital Anxiety and Depression Scale (HADS)Participants that agree to take part in this study, partiicpants will have a virtual visit, via Zoom, about 7 days after you are discharged from the hospital. The visit will take about 20 minutes, and you will meet with a member of the research team to complete several questionnaires. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- MD Anderson Cancer Center
Key inclusion criteria (4 listed)
- Adult patient with cancer admitted for cancer-related surgery
- inpatient surgical hospital stay lasting at least 23 hours
- discharged home with a prescription for opioid analgesics
- able to read, speak, and consent in English.
Key exclusion criteria (3 listed)
- Age less than 18 years
- not discharged with a prescription for opioid analgesia to manage pain
- individuals for whom there is documentation of inability to provide consent in the medical record.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 13-item Barriers Questionnaire (BQ-13)Given by questionnaire | Other | Opiophobia in Postsurgical Adults |
| Four-item Medication Adherence QuestionnaireGiven by questionnaire | Other | Opiophobia in Postsurgical Adults |
| 14-item Hospital Anxiety and Depression Scale (HADS)Given by questionnaire | Other | Opiophobia in Postsurgical Adults |
Primary outcome
To explore the barriers and fears related to use of opioids among a population of adults who underwent surgery for cancer.
Time frame: Through study completion, an average of 1 year.
Use of opioids among a population of adults who underwent surgery for cancer.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Oct 2026.
- MD Anderson Cancer CenterLink provided by the sponsor.
Related trials for Opiophobia
Active, not recruitingObservational study
Opiophobia in Adults With Advanced Cancer
Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Eileen Hacker, PHD,RN principal investigator
M.D. Anderson Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Opiophobia, run by M.D. Anderson Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To explore the barriers and fears related to use of opioids among a population of adults who underwent surgery for cancer. (time frame: Through study completion, an average of 1 year.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026.